Top-Rated Breast Cancer Charities for 2024
Top-Rated Breast Cancer Charities for 2024
Oct 24, 2024
October is Breast Cancer Awareness Month.
October is Breast Cancer Awareness Month.
Top-Rated Charity
Website
View similar charities
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| Cancer Research Institute | IRS Form 990 | 13-1837442 |
| Cancer Research Institute | Audited Financial Statements | 13-1837442 |
|
Entity: Cancer Research Institute Document Type: IRS Form 990 Tax ID: 13-1837442 |
|
Entity: Cancer Research Institute Document Type: Audited Financial Statements Tax ID: 13-1837442 |
Governance & Transparency
CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Jill O'Donnell-Tormey, Ph.D. | CEO/Director Of Scientific Affairs | $602,303 |
| 2 | Alfred R. Massidas | CFO/Director of Human Resources | $425,801 |
| 3 | Lynne A. Rapino | Chief Program Officer | $364,304 |
|
1 Name: Jill O'Donnell-Tormey, Ph.D. Title: CEO/Director Of Scientific Affairs Compensation: $602,303 |
|
2 Name: Alfred R. Massidas Title: CFO/Director of Human Resources Compensation: $425,801 |
|
3 Name: Lynne A. Rapino Title: Chief Program Officer Compensation: $364,304 |
Analysts' Notes
CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the Cancer Research Institute audit of June 30, 2023 (Note A-16 re: Contributed services), the Institute received in-kind contributed services provided by the Institute's Scientific Advisory Council in fiscal 2023 on which it placed a total value of $501,480. [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |
According to the Cancer Research Institute audit of June 30, 2023 (Note B-1, Contributions and grants receivable): "...Included in contribution revenue for fiscal-years 2023 and 2022, was an amount of $3,750,000 from one donor for both years, which represented approximately 11% and 12%, respectively, of the total operating support and revenue for each fiscal-year." |
According to the Cancer Research Institute audit of June 30, 2023 (Note E, PPP Loan Payable): "On May 1, 2020, the Institute received $710,150 in funds from the PPP. During fiscal-year 2022, the Institute applied for and received forgiveness of the PPP loan from the bank and SBA. The Institute's application for forgiveness of the PPP loan was approved by the bank and the SBA during fiscal-year 2022 and, accordingly, the Institute recognized a gain on loan forgiveness of $710,150 in the statements of activities for the fiscal year-ended June 30, 2022. Accordingly, the Institute reported a gain on loan forgiveness in the statements of activities for fiscal-year 2022." |